| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.04B | +5.5% |
| Cost of Revenue | $5.56B | +3.9% |
| Gross Profit | $3.48B | +8.2% |
| R&D Expense | $226.0M | -1.7% |
| SG&A Expense | $1.92B | +0.6% |
| Operating Income | $1.22B | +21.2% |
| Pre-tax Income | $1.18B | +8.6% |
| Income Tax | $231.0M | +17.3% |
| Net Income | $957.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.48B | +31.9% |
| Accounts Receivable | $1.76B | +5.5% |
| Inventory | $983.0M | -1.3% |
| Current Assets | $4.64B | +13.3% |
| Total Assets | $17.63B | +6.9% |
| Current Liabilities | $2.86B | +22.3% |
| Long-term Debt | $1.95B | -3.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.24B | -1.7% |
| Investing Cash Flow | -$471.0M | +2.3% |
| Financing Cash Flow | -$501.0M | +18.5% |
| +7.5% |
| EPS (Basic) | $3.93 | +7.1% |
| EPS (Diluted) | $3.92 | +7.4% |
| Total Liabilities |
| $5.88B |
| +4.9% |
| Stockholders' Equity | $11.48B | +7.9% |